Aclene0.1%

Aclene is a topical retinoid indicated for the following use:

• Acne vulgaris (established/approved use): Aclene gel/cream is indicated for the topical treatment of acne vulgaris in patients, typically for mild to moderate comedonal and inflammatory acne affecting the face, chest, or back.

Aclene is commonly combined with benzoyl peroxide or topical/oral antibiotics as combination therapy for moderate to severe inflammatory acne, since it does not have significant antibacterial activity on its own. It is not indicated for any condition other than acne vulgaris, and it is not effective against cystic or nodular acne when used alone.

Each formulation typically contains Adapalene as the active ingredient at a strength of 0.1% or 0.3% w/w, formulated as a topical gel, cream, or lotion. Common inactive ingredients include carbomer, edetate disodium, methylparaben, poloxamer 182, propylene glycol, purified water, and other gel/cream base excipients (exact excipients vary by manufacturer and formulation).

Aclene is a third-generation synthetic topical retinoid (a naphthoic acid derivative) used primarily in dermatology for the treatment of acne vulgaris. Unlike older retinoids such as tretinoin, Aclene is chemically stable in light and in the presence of oxidizing agents such as benzoyl peroxide, allowing it to be combined with benzoyl peroxide in a single product.

Aclene is available as a topical gel, cream, or lotion, usually in 0.1% or 0.3% strength, and is applied once daily to affected areas of skin.

Aclene belongs to the therapeutic class of topical retinoids (anti-acne agents), used in dermatology for the management of acne vulgaris.

Mechanism of Action

Adapalene is a retinoid-like compound that binds to specific retinoic acid nuclear receptors (RAR-beta and RAR-gamma) but not to cytosolic retinoic acid-binding protein. Through retinoic-acid-receptor binding, Adapalene normalizes the differentiation of follicular epithelial cells, resulting in decreased microcomedone formation. Adapalene also has anti-inflammatory and comedolytic properties: it inhibits chemotactic and chemokinetic responses of human polymorphonuclear leukocytes and inhibits lipoxygenase-dependent metabolism of arachidonic acid, which is thought to contribute to its anti-inflammatory activity in acne lesions.

Pharmacokinetics

Systemic absorption of Adapalene through intact skin is minimal following topical application. In studies using radiolabeled drug, plasma concentrations of Adapalene were below the limit of quantification, indicating very low systemic bioavailability with normal topical use.

Aclene is for topical use on the skin only. Cleanse and dry the affected area first. Apply a thin, even film over the entire affected area (not just individual spots), avoiding the eyes, lips, and mucous membranes. Use sunscreen and limit sun exposure during treatment, as Aclene can increase skin photosensitivity.

Because Aclene has minimal systemic absorption when applied topically, clinically significant systemic drug-drug interactions are unlikely. However, the following local/topical interactions are clinically relevant:

• Other topical retinoids or peeling agents (e.g., tretinoin, tazarotene, salicylic acid, sulfur, resorcinol): Concurrent use with Aclene may cause additive skin irritation, dryness, and peeling; avoid combining unless directed by a physician.
• High-concentration alcohol-, astringent-, or spice-containing topical products, and abrasive/drying cosmetic products: May increase local irritation when used with Aclene; use with caution.
• Photosensitizing agents/procedures (e.g., other photosensitizing drugs, waxing, or UV therapy): May increase risk of irritation or photosensitivity when combined with Aclene.

Aclene is chemically compatible with benzoyl peroxide (unlike some older retinoids) and is often formulated in fixed-dose combination products with it.

The most common adverse effects of topical Aclene are local skin reactions, particularly during the initial weeks of treatment ("retinization"):

• Dryness, scaling, and peeling of the skin
• Erythema (redness)
• Burning or stinging sensation
• Pruritus (itching)
• Sunburn or increased photosensitivity

An initial worsening of acne (increased redness or breakouts) is possible during the first 2-4 weeks of therapy as deeper microcomedones are brought to the surface; this is common and does not necessarily indicate treatment failure. Local skin irritation typically decreases with continued use as the skin adjusts. Severe irritation, blistering, or crusting should be reported to a physician.

Pregnancy: Aclene is a retinoid, and retinoids as a class are associated with concerns about teratogenicity, although systemic absorption from topical Aclene is much lower than with oral retinoids. Aclene should be used during pregnancy only if clearly needed and the potential benefit justifies the potential risk to the fetus. Discuss use with a physician before starting or continuing Aclene if pregnant or planning pregnancy.

Lactation: It is not known whether topically applied Aclene is excreted in human milk in clinically significant amounts. Caution should be exercised when Aclene is used by a breastfeeding woman; avoid applying to the chest/breast area to prevent direct infant contact, and consult a physician before use.

• Skin irritation: Aclene may cause significant local irritation (redness, dryness, peeling, burning), especially during the first few weeks of use. Start with less frequent application if irritation is significant, and consult a physician if irritation is severe or persistent.
• Photosensitivity: Aclene may increase sensitivity to sunlight. Minimize sun exposure and use sunscreen and protective clothing during treatment. Avoid sunlamps and tanning beds.
• Avoid irritated or damaged skin: Do not apply Aclene to cuts, abrasions, sunburned, eczematous, or otherwise compromised skin.
• Concomitant products: Avoid concurrent use of other potentially irritating topical products (other retinoids, high-concentration exfoliants/peels, strong alcohol- or astringent-based products) unless directed by a physician, due to additive irritation risk.
• Avoid mucous membranes and eyes: Keep away from the eyes, lips, angles of the nose, and mucous membranes; if accidental contact occurs, rinse thoroughly with water.
• Extreme weather: Weather extremes such as wind or cold may be more irritating to skin treated with Aclene.
• For external use only; not for oral, ophthalmic, or intravaginal use.

Topical Aclene is not intended for oral use. Excessive topical application does not speed clinical results and increases the risk of marked redness, peeling, or discomfort; if excessive local irritation occurs, discontinue use temporarily and consult a physician. If Aclene gel/cream is accidentally ingested in significant quantity, seek immediate medical attention or contact a poison control center; general supportive care may be indicated as directed by a physician or emergency services.

Store at room temperature (below 30°C), away from light and moisture. Keep the tube tightly closed after use. Keep out of reach of children.

• Pediatric use: Aclene 0.1% is approved for patients 12 years of age and older with acne vulgaris; safety and efficacy in children below 12 years have not been established. The 0.3% strength is generally studied and used in adults and adolescents 12 years and older as well.
• Elderly: Clinical studies of Aclene did not include sufficient numbers of elderly patients to determine differences in response; acne vulgaris is uncommon in this age group, and use should be individualized.
• Renal/hepatic impairment: No specific dose adjustment is established, given minimal systemic absorption with topical use.
• Pregnancy and lactation: See Pregnancy and Lactation section — use only if clearly needed, under physician guidance.
• Patients with sensitive or compromised skin: Use with caution in patients with eczema or very sensitive skin, as irritation may be more pronounced.

Aclene is generally used as a long-term maintenance therapy for acne vulgaris. Visible improvement typically takes 8-12 weeks of consistent daily use, and treatment is often continued for several months for optimal results. Long-term use (months to years) under physician supervision is common for maintenance of clear skin. Do not stop treatment abruptly without consulting a physician, as acne may recur.

Adapalene belongs to the class of topical retinoids (naphthoic acid derivatives), a subclass of retinoid-like compounds used for the treatment of acne vulgaris.

Adapalene binds selectively to retinoic acid nuclear receptors (RAR-beta and RAR-gamma) in skin cells, modulating cellular differentiation, keratinization, and inflammatory processes. This normalizes the differentiation of follicular epithelial cells, reducing the formation of microcomedones (the precursor lesion of acne), and exerts anti-inflammatory effects by inhibiting neutrophil chemotaxis and lipoxygenase-mediated arachidonic acid metabolism. The net effect is a reduction in both comedonal and inflammatory acne lesions over time.

C

Aclene 0.1% gel/cream is approved for the topical treatment of acne vulgaris in patients 12 years of age and older. Safety and efficacy in children younger than 12 years have not been established, and use in this age group is not recommended without physician guidance. Adolescent patients should be counseled on proper application technique, sun protection, and the expected initial "purging" period, similar to adult patients.